Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NQL2: Variant p.Ser76Trp

Ras-related GTP-binding protein D
Gene: RRAGD
Feedback?
Variant information Variant position: help 76 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Serine (S) to Tryptophan (W) at position 76 (S76W, p.Ser76Trp). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and polar (S) to large size and aromatic (W) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In HOMG7; increased positive regulation of TORC1 signaling; increased phosphorylation of the downstream molecule S6K1. Any additional useful information about the variant.


Sequence information Variant position: help 76 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 400 The length of the canonical sequence.
Location on the sequence: help PFSTEVKPRILLMGLRRSGK S SIQKVVFHKMSPNETLFLES The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PFSTEVKPRILLMGLRRSGKSSIQKVVFHKMSPNETLFLES

Mouse                         PFSTEVKPRILLMGLRRSGKSSIQKVVFHKMSPSETLFLES
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 400 Ras-related GTP-binding protein D
Binding site 71 – 71
Binding site 72 – 72
Binding site 72 – 72
Binding site 73 – 73
Binding site 73 – 73
Binding site 74 – 74
Binding site 74 – 74
Binding site 75 – 75
Binding site 75 – 75
Binding site 76 – 76
Binding site 76 – 76
Binding site 77 – 77
Binding site 77 – 77
Binding site 91 – 91
Binding site 91 – 91
Binding site 95 – 95
Alternative sequence 1 – 151 Missing. In isoform 2.
Helix 75 – 84



Literature citations
mTOR-Activating Mutations in RRAGD Are Causative for Kidney Tubulopathy and Cardiomyopathy.
Schlingmann K.P.; Jouret F.; Shen K.; Nigam A.; Arjona F.J.; Dafinger C.; Houillier P.; Jones D.P.; Kleinerueschkamp F.; Oh J.; Godefroid N.; Eltan M.; Gueran T.; Burtey S.; Parotte M.C.; Koenig J.; Braun A.; Bos C.; Ibars Serra M.; Rehmann H.; Zwartkruis F.J.T.; Renkema K.Y.; Klingel K.; Schulze-Bahr E.; Schermer B.; Bergmann C.; Altmueller J.; Thiele H.; Beck B.B.; Dahan K.; Sabatini D.; Liebau M.C.; Vargas-Poussou R.; Knoers N.V.A.M.; Konrad M.; de Baaij J.H.F.;
J. Am. Soc. Nephrol. 32:2885-2899(2021)
Cited for: INVOLVEMENT IN HOMG7; VARIANTS HOMG7 LEU-76; TRP-76; PRO-97; ARG-119; LEU-119 AND LYS-221; CHARACTERIZATION OF VARIANTS HOMG7 LEU-76; TRP-76; PRO-97; ARG-119; LEU-119 AND LYS-221; FUNCTION;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.